1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Monoclonal Antibodies 1.2.3 Caspase Protease Inhibitor 1.2.4 Corticosteroids 1.2.5 Hemorheologic Agents 1.2.6 Anabolic Steroids 1.2.7 Hepatotropic Hormones 1.2.8 Sulfhydryl Agents 1.2.9 Others 1.3 Market by Application 1.3.1 Global Alcoholic Hepatitis Therapeutic Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals and Clinics 1.3.3 Research and Development 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Alcoholic Hepatitis Therapeutic Market Perspective (2016-2027) 2.2 Alcoholic Hepatitis Therapeutic Growth Trends by Regions 2.2.1 Alcoholic Hepatitis Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Alcoholic Hepatitis Therapeutic Historic Market Share by Regions (2016-2021) 2.2.3 Alcoholic Hepatitis Therapeutic Forecasted Market Size by Regions (2022-2027) 2.3 Alcoholic Hepatitis Therapeutic Industry Dynamic 2.3.1 Alcoholic Hepatitis Therapeutic Market Trends 2.3.2 Alcoholic Hepatitis Therapeutic Market Drivers 2.3.3 Alcoholic Hepatitis Therapeutic Market Challenges 2.3.4 Alcoholic Hepatitis Therapeutic Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Alcoholic Hepatitis Therapeutic Players by Revenue 3.1.1 Global Top Alcoholic Hepatitis Therapeutic Players by Revenue (2016-2021) 3.1.2 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Players (2016-2021) 3.2 Global Alcoholic Hepatitis Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Alcoholic Hepatitis Therapeutic Revenue 3.4 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio 3.4.1 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Alcoholic Hepatitis Therapeutic Revenue in 2020 3.5 Alcoholic Hepatitis Therapeutic Key Players Head office and Area Served 3.6 Key Players Alcoholic Hepatitis Therapeutic Product Solution and Service 3.7 Date of Enter into Alcoholic Hepatitis Therapeutic Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Alcoholic Hepatitis Therapeutic Breakdown Data by Type 4.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Type (2016-2021) 4.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Type (2022-2027) 5 Alcoholic Hepatitis Therapeutic Breakdown Data by Application 5.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Application (2016-2021) 5.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Alcoholic Hepatitis Therapeutic Market Size (2016-2027) 6.2 North America Alcoholic Hepatitis Therapeutic Market Size by Type 6.2.1 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) 6.2.2 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) 6.2.3 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2027) 6.3 North America Alcoholic Hepatitis Therapeutic Market Size by Application 6.3.1 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) 6.3.2 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) 6.3.3 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2027) 6.4 North America Alcoholic Hepatitis Therapeutic Market Size by Country 6.4.1 North America Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) 6.4.2 North America Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Alcoholic Hepatitis Therapeutic Market Size (2016-2027) 7.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Type 7.2.1 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) 7.2.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) 7.2.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2027) 7.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Application 7.3.1 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) 7.3.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) 7.3.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2027) 7.4 Europe Alcoholic Hepatitis Therapeutic Market Size by Country 7.4.1 Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) 7.4.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size (2016-2027) 8.2 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type 8.2.1 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2027) 8.3 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application 8.3.1 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2027) 8.4 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region 8.4.1 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Alcoholic Hepatitis Therapeutic Market Size (2016-2027) 9.2 Latin America Alcoholic Hepatitis Therapeutic Market Size by Type 9.2.1 Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) 9.2.2 Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) 9.2.3 Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2027) 9.3 Latin America Alcoholic Hepatitis Therapeutic Market Size by Application 9.3.1 Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) 9.3.2 Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) 9.3.3 Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2027) 9.4 Latin America Alcoholic Hepatitis Therapeutic Market Size by Country 9.4.1 Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) 9.4.2 Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size (2016-2027) 10.2 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type 10.2.1 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2027) 10.3 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application 10.3.1 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2027) 10.4 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country 10.4.1 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Alkermes 11.1.1 Alkermes Company Details 11.1.2 Alkermes Business Overview 11.1.3 Alkermes Alcoholic Hepatitis Therapeutic Introduction 11.1.4 Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) 11.1.5 Alkermes Recent Development 11.2 Conatus pharmaceuticals 11.2.1 Conatus pharmaceuticals Company Details 11.2.2 Conatus pharmaceuticals Business Overview 11.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction 11.2.4 Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) 11.2.5 Conatus pharmaceuticals Recent Development 11.3 Dainippon sumitomo pharma 11.3.1 Dainippon sumitomo pharma Company Details 11.3.2 Dainippon sumitomo pharma Business Overview 11.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Introduction 11.3.4 Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) 11.3.5 Dainippon sumitomo pharma Recent Development 11.4 Generon corporation 11.4.1 Generon corporation Company Details 11.4.2 Generon corporation Business Overview 11.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Introduction 11.4.4 Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) 11.4.5 Generon corporation Recent Development 11.5 Immuron limited 11.5.1 Immuron limited Company Details 11.5.2 Immuron limited Business Overview 11.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Introduction 11.5.4 Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) 11.5.5 Immuron limited Recent Development 11.6 Lupin Laboratories 11.6.1 Lupin Laboratories Company Details 11.6.2 Lupin Laboratories Business Overview 11.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Introduction 11.6.4 Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) 11.6.5 Lupin Laboratories Recent Development 11.7 Intercept Pharmaceuticals 11.7.1 Intercept Pharmaceuticals Company Details 11.7.2 Intercept Pharmaceuticals Business Overview 11.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction 11.7.4 Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) 11.7.5 Intercept Pharmaceuticals Recent Development 11.8 Teva Pharmaceuticals 11.8.1 Teva Pharmaceuticals Company Details 11.8.2 Teva Pharmaceuticals Business Overview 11.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction 11.8.4 Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) 11.8.5 Teva Pharmaceuticals Recent Development 11.9 Sanofi-Aventis 11.9.1 Sanofi-Aventis Company Details 11.9.2 Sanofi-Aventis Business Overview 11.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Introduction 11.9.4 Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) 11.9.5 Sanofi-Aventis Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Monoclonal Antibodies Table 3. Key Players of Caspase Protease Inhibitor Table 4. Key Players of Corticosteroids Table 5. Key Players of Hemorheologic Agents Table 6. Key Players of Anabolic Steroids Table 7. Key Players of Hepatotropic Hormones Table 8. Key Players of Sulfhydryl Agents Table 9. Key Players of Others Table 10. Global Alcoholic Hepatitis Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Alcoholic Hepatitis Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Alcoholic Hepatitis Therapeutic Market Size by Regions (2016-2021) & (US$ Million) Table 13. Global Alcoholic Hepatitis Therapeutic Market Share by Regions (2016-2021) Table 14. Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 15. Global Alcoholic Hepatitis Therapeutic Market Share by Regions (2022-2027) Table 16. Alcoholic Hepatitis Therapeutic Market Trends Table 17. Alcoholic Hepatitis Therapeutic Market Drivers Table 18. Alcoholic Hepatitis Therapeutic Market Challenges Table 19. Alcoholic Hepatitis Therapeutic Market Restraints Table 20. Global Alcoholic Hepatitis Therapeutic Revenue by Players (2016-2021) & (US$ Million) Table 21. Global Alcoholic Hepatitis Therapeutic Market Share by Players (2016-2021) Table 22. Global Top Alcoholic Hepatitis Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcoholic Hepatitis Therapeutic as of 2020) Table 23. Ranking of Global Top Alcoholic Hepatitis Therapeutic Companies by Revenue (US$ Million) in 2020 Table 24. Global 5 Largest Players Market Share by Alcoholic Hepatitis Therapeutic Revenue (CR5 and HHI) & (2016-2021) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Alcoholic Hepatitis Therapeutic Product Solution and Service Table 27. Date of Enter into Alcoholic Hepatitis Therapeutic Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 30. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2016-2021) Table 31. Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million) Table 32. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million) Table 33. Global Alcoholic Hepatitis Therapeutic Market Size Share by Application (2016-2021) & (US$ Million) Table 34. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Application (2016-2021) Table 35. Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million) Table 36. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million) Table 37. North America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 38. North America Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 39. North America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 40. North America Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 41. North America Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 42. North America Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 43. Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 44. Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 45. Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 46. Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 47. Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 48. Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 49. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 50. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 51. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 52. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 53. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region (2022-2027) & (US$ Million) Table 55. Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 56. Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 57. Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 58. Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 59. Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 60. Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 61. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million) Table 62. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) & (US$ Million) Table 63. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) (US$ Million) Table 64. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) & (US$ Million) Table 65. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) & (US$ Million) Table 66. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) & (US$ Million) Table 67. Alkermes Company Details Table 68. Alkermes Business Overview Table 69. Alkermes Alcoholic Hepatitis Therapeutic Product Table 70. Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million) Table 71. Alkermes Recent Development Table 72. Conatus pharmaceuticals Company Details Table 73. Conatus pharmaceuticals Business Overview Table 74. Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Product Table 75. Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million) Table 76. Conatus pharmaceuticals Recent Development Table 77. Dainippon sumitomo pharma Company Details Table 78. Dainippon sumitomo pharma Business Overview Table 79. Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Product Table 80. Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million) Table 81. Dainippon sumitomo pharma Recent Development Table 82. Generon corporation Company Details Table 83. Generon corporation Business Overview Table 84. Generon corporation Alcoholic Hepatitis Therapeutic Product Table 85. Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million) Table 86. Generon corporation Recent Development Table 87. Immuron limited Company Details Table 88. Immuron limited Business Overview Table 89. Immuron limited Alcoholic Hepatitis Therapeutic Product Table 90. Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million) Table 91. Immuron limited Recent Development Table 92. Lupin Laboratories Company Details Table 93. Lupin Laboratories Business Overview Table 94. Lupin Laboratories Alcoholic Hepatitis Therapeutic Product Table 95. Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million) Table 96. Lupin Laboratories Recent Development Table 97. Intercept Pharmaceuticals Company Details Table 98. Intercept Pharmaceuticals Business Overview Table 99. Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Product Table 100. Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million) Table 101. Intercept Pharmaceuticals Recent Development Table 102. Teva Pharmaceuticals Company Details Table 103. Teva Pharmaceuticals Business Overview Table 104. Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million) Table 105. Teva Pharmaceuticals Recent Development Table 106. Sanofi-Aventis Company Details Table 107. Sanofi-Aventis Business Overview Table 108. Sanofi-Aventis Alcoholic Hepatitis Therapeutic Product Table 109. Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million) Table 110. Sanofi-Aventis Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Alcoholic Hepatitis Therapeutic Market Share by Type: 2020 VS 2027 Figure 2. Monoclonal Antibodies Features Figure 3. Caspase Protease Inhibitor Features Figure 4. Corticosteroids Features Figure 5. Hemorheologic Agents Features Figure 6. Anabolic Steroids Features Figure 7. Hepatotropic Hormones Features Figure 8. Sulfhydryl Agents Features Figure 9. Others Features Figure 10. Global Alcoholic Hepatitis Therapeutic Market Share by Application: 2020 VS 2027 Figure 11. Hospitals and Clinics Case Studies Figure 12. Research and Development Case Studies Figure 13. Alcoholic Hepatitis Therapeutic Report Years Considered Figure 14. Global Alcoholic Hepatitis Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Alcoholic Hepatitis Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Alcoholic Hepatitis Therapeutic Market Share by Regions: 2020 VS 2027 Figure 17. Global Alcoholic Hepatitis Therapeutic Market Share by Regions (2022-2027) Figure 18. Global Alcoholic Hepatitis Therapeutic Market Share by Players in 2020 Figure 19. Global Top Alcoholic Hepatitis Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcoholic Hepatitis Therapeutic as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Alcoholic Hepatitis Therapeutic Revenue in 2020 Figure 21. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2016-2021) Figure 22. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2022-2027) Figure 23. North America Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Alcoholic Hepatitis Therapeutic Market Share by Type (2016-2027) Figure 25. North America Alcoholic Hepatitis Therapeutic Market Share by Application (2016-2027) Figure 26. North America Alcoholic Hepatitis Therapeutic Market Share by Country (2016-2027) Figure 27. United States Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Alcoholic Hepatitis Therapeutic Market Share by Type (2016-2027) Figure 31. Europe Alcoholic Hepatitis Therapeutic Market Share by Application (2016-2027) Figure 32. Europe Alcoholic Hepatitis Therapeutic Market Share by Country (2016-2027) Figure 33. Germany Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Share by Type (2016-2027) Figure 41. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Share by Application (2016-2027) Figure 42. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Share by Region (2016-2027) Figure 43. China Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Alcoholic Hepatitis Therapeutic Market Share by Type (2016-2027) Figure 51. Latin America Alcoholic Hepatitis Therapeutic Market Share by Application (2016-2027) Figure 52. Latin America Alcoholic Hepatitis Therapeutic Market Share by Country (2016-2027) Figure 53. Mexico Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Share by Type (2016-2027) Figure 57. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Share by Application (2016-2027) Figure 58. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Share by Country (2016-2027) Figure 59. Turkey Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Alkermes Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021) Figure 63. Conatus pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021) Figure 64. Dainippon sumitomo pharma Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021) Figure 65. Generon corporation Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021) Figure 66. Immuron limited Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021) Figure 67. Lupin Laboratories Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021) Figure 68. Intercept Pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021) Figure 69. Teva Pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021) Figure 70. Sanofi-Aventis Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Alkermes Conatus pharmaceuticals Dainippon sumitomo pharma Generon corporation Immuron limited Lupin Laboratories Intercept Pharmaceuticals Teva Pharmaceuticals Sanofi-Aventis